SCHEMBL8930489

SCHEMBL8930489

CCCCCCN1CCN(C2=Nc3cc(Cl)ccc3Oc3ccccc32)CC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 10/20 0.71
DRD4 P21917 6/20 0.71
DRD2 P14416 5/20 0.71
HRH2 P25021 3/20 0.61
HRH1 P35367 3/20 0.61
HRH3 Q9Y5N1 1/20 0.61
HTR2A P28223 5/20 0.59
ADRA2A P08913 5/20 0.59
HTR1A P08908 4/20 0.59
HTR2C P28335 3/20 0.59
ADRB2 P07550 2/20 0.59
CHRM2 P08172 2/20 0.59
CHRM4 P08173 2/20 0.59
CHRM5 P08912 2/20 0.59
ADORA3 P0DMS8 2/20 0.59
CHRM1 P11229 2/20 0.59
ADRA2B P18089 2/20 0.59
ADRA2C P18825 2/20 0.59
CHRM3 P20309 2/20 0.59
DRD1 P21728 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8930496 1.00 HRH4 (0.71) HRH4DRD4DRD2HRH2HRH1
SCHEMBL9081964 1.00 HRH4 (0.71) HRH4DRD4DRD2HRH2HRH1
SCHEMBL9079680 1.00 HRH4 (0.71) HRH4DRD4DRD2HRH2HRH1
SCHEMBL3836813 0.96 HRH4 (0.74) HRH4DRD4DRD2HRH2HRH1
SCHEMBL3855338 0.92 HRH4 (0.77) HRH4DRD4DRD2HRH2HRH1
SCHEMBL8930480 0.88 HRH4 (0.67) HRH4DRD4DRD2HRH2HRH1
SCHEMBL9078990 0.88 HRH4 (0.67) HRH4DRD4DRD2HRH2HRH1
SCHEMBL8930476 0.88 HRH4 (0.67) HRH4DRD4DRD2HRH2HRH1
SCHEMBL4192075 0.87 HRH4 (0.83) HRH4DRD4DRD2HRH2HRH1
Hydrochloric Acid SCHEMBL3838758 0.86 HRH4 (0.81) HRH4DRD4DRD2HRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602121-A ANTISCHIZOPHRENIA AGENTS ALLELIX BIOPHARMACEUTICALS, INC. (CA) 1997-02-11 US disclosed
WO-1996018621-A1 ALKYL-SUBSTITUTED COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY ALLELIX BIOPHARMACEUTICALS INC. (US) 1996-06-20 WO disclosed